Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

PURPOSE: Therapy with [(177)Lu-DOTA,Tyr(3)]octreotate is effective in patients with grade I/II metastasized and/or inoperable bronchial neuroendocrine tumour (NET) or gastroenteropancreatic NET (GEP-NET). In this study, we investigated the efficacy and safety of salvage treatment with [(177)Lu-DOTA,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: van der Zwan, W. A., Brabander, T., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., Krenning, E. P., de Herder, W. W.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351514/
https://ncbi.nlm.nih.gov/pubmed/30267116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4158-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars